Ovarian lesions due to cytostatic agents during the treatment of Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006062:Gonadotropins / Q000652:urine; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects; D010049:Ovarian Diseases / Q000139:chemically induced* / Q000175:diagnosis; D014626:Vaginal Smears; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D006062:Gonadotropins; D006834:Hydrazines; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide